References
- Ajani JA, Takiuchi H. Recent developments in oral chemotherapy option for gastric carcinoma. Drugs 1999; 58: 85–90
- Forster KA, Yazdanian M, Audus KL. Microparticulate uptake mechanisms: Effect of particle size, cell line and cell density. J Control Release 2001; 71: 39–51
- Gardner SN. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs. Cancer Res 2000; 60: 1417–1425
- Gardner SN. Cell cycle phase-specific chemotherapy computational methods for guiding treatment. Cell Cycle 2002; 6: 369–374
- Kopecek J, Kopeckova P, Minko T, Lu Z-R, Peterson CM. Water soluble polymers in tumor targeted delivery. J Control Release 2001; 74: 147–158
- Kwon GS, Okano T. Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 1996; 21: 107–116
- Lu Z-R, Shiah JG, kopecek J, Kopeckova P. Preparation and biological evalution of polymerizable antibody Fab'fragment targeted polymeric drug delivery system. J Control Release 2001; 74: 263–268
- Marecos E, Weissleder R, Bogdanov A, Jr. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjug Chem 1998; 9: 184–191
- Matsumura Y, Haeda H. A new concept for macromoleular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and antitumor agent amancs. Cancer Res 1986; 46: 6387–6392
- McClean S, Prosser E, Mechen E, Omalley D, Clarke N, Ramtoola Z, Brayden D. Binding and uptake of biodegradable poly dl-lactide micro and nanoparticles in intestinal epithelia. Eur J Pharm Sci 1998; 6: 153–156
- Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, Maeda H. Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissue. Jpn J Cancer Res 1998; 89: 307–314
- Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly (dl-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J 2002; 16: 1217–1226
- son YJ, Jang JS, Cho YW, Chung HS, Park RW, Kwon 1C, Kim IS, Pask JY, Seo SB, Park CR, Jeong SY. Biodistribution and anti-tumor efficacy of doxorubicin loaded glycol–chitosan nanoaggregates by EPR effect. J Control Release 2003; 91: 135–145
- Suh H, Jeong B, Liu F, Kim SW. Cellular uptake study of biodegradable nanoparticles in vascular smooth muscle cells. Pharm Res 1998; 15: 1495–1498
- Yoo HS, Park TG. Biodegradable micelles composed of doxorubicin conjugated PLGA–PEG block copolymer. J Control Release 2001; 70: 63–70
- Yoo HS, Park TG. Folate rceptor targeted biodegeradable polymeric doxorubicin micelles. J Control Release 2004; 96: 273–283
- Yoo HS, Lee KH, Oh JE, Park TG. In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates. J Control Release 2000; 68: 419–431
- Yu JJ, Jeong YI, Shim YH, Lim GT. Preparation of core shell type nanoparticles of diblock copolymers of poly (l-lactide)/Poly (ethylene glycol) and their characterization in vitro. J Appl Polym Sci 2002; 85: 2625–2634